Steven Kelly
Algemeen Directeur bij CARISMA THERAPEUTICS, INC.
Vermogen: 1 118 $ op 30-04-2024
Actieve functies van Steven Kelly
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARTELO BIOSCIENCES, INC. | Directeur/Bestuurslid | 02-05-2017 | - |
| Independent Dir/Board Member | 02-05-2017 | - | |
| CARISMA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-02-2018 | - |
| Algemeen Directeur | 01-02-2018 | - | |
| President | 01-02-2018 | - | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Directeur/Bestuurslid | 23-04-2018 | - |
| Algemeen Directeur | 23-04-2018 | - | |
| Oprichter | 23-04-2018 | - | |
| President | 23-04-2018 | - |
Loopbaan van Steven Kelly
Eerdere bekende functies van Steven Kelly
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Kelly Bioconsulting LLC
 Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder. | Corporate Officer/Principal | 01-01-2012 | 01-01-2018 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Algemeen Directeur | 01-04-2014 | 01-07-2015 |
| President | 01-04-2014 | 01-07-2015 | |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Algemeen Directeur | 01-06-2011 | 01-08-2012 |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | President | 01-06-2004 | 11-10-2010 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Corporate Officer/Principal | 02-07-2010 | - |
Opleiding van Steven Kelly
| Cornell University | Masters Business Admin |
| University of Oregon | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 11 |
Operationeel
| President | 4 |
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARTELO BIOSCIENCES, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Health Technology |
Kelly Bioconsulting LLC
Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder. | Commercial Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Theracrine, Inc.
Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Steven Kelly
- Ervaring
